Add-On Cemiplimab Shows Promise as First-Line Treatment for Penile Cancer

[ad_1]

(MedPage Today) — SAN FRANCISCO — A combination of cemiplimab (Libtayo) and standard-of-care chemotherapy appeared to be effective in patients with locally advanced or metastatic penile cancer, according to findings from a phase II study….

[ad_2]

Source link : https://www.medpagetoday.com/meetingcoverage/mgucs/114248

Author :

Publish date : 2025-02-16 18:53:58

Copyright for syndicated content belongs to the linked Source.